Cargando…
Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798466/ https://www.ncbi.nlm.nih.gov/pubmed/35117479 http://dx.doi.org/10.21037/tcr.2020.01.16 |
| _version_ | 1784641813910388736 |
|---|---|
| author | Kwon, Whi-An Seo, Ho Kyung |
| author_facet | Kwon, Whi-An Seo, Ho Kyung |
| author_sort | Kwon, Whi-An |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8798466 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87984662022-02-02 Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer Kwon, Whi-An Seo, Ho Kyung Transl Cancer Res Editorial Commentary AME Publishing Company 2020-03 /pmc/articles/PMC8798466/ /pubmed/35117479 http://dx.doi.org/10.21037/tcr.2020.01.16 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Commentary Kwon, Whi-An Seo, Ho Kyung Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| title | Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| title_full | Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| title_fullStr | Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| title_full_unstemmed | Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| title_short | Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| title_sort | novel g9a/dnmt first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798466/ https://www.ncbi.nlm.nih.gov/pubmed/35117479 http://dx.doi.org/10.21037/tcr.2020.01.16 |
| work_keys_str_mv | AT kwonwhian novelg9adnmtfirstinclassdualreversibleinhibitorhaspotentantitumoreffectinbladdercancer AT seohokyung novelg9adnmtfirstinclassdualreversibleinhibitorhaspotentantitumoreffectinbladdercancer |